Display options
Cite
Sokolov AA, Rossetti AO, Michel P, et al. Neurologie. [Neurology]. Rev Med Suisse. 2016;12(500):62, 64-6
Sokolov, A. A., Rossetti, A. O., Michel, P., Benninger, D., Nater, B., Wider, C., Hirt, L., Kuntzer, T., Démonet, J. F., Du Pasquier, R. A., & Vingerhoets, F. (2016). Neurologie. [Neurology]. Revue medicale suisse, 12(500), 62, 64-6.
Sokolov, Arseny A, et al. "Neurologie." [Neurology]. Revue medicale suisse vol. 12,500 (2016): 62, 64-6.
Sokolov AA, Rossetti AO, Michel P, Benninger D, Nater B, Wider C, Hirt L, Kuntzer T, Démonet JF, Du Pasquier RA, Vingerhoets F. Neurologie. [Neurology]. Rev Med Suisse. 2016 Jan 13;12(500):62, 64-6. French. PMID: 26946707.
Copy Download .nbib Format: NLM
Share it on

Rev Med Suisse. 2016 Jan 13;12(500):62, 64-6.

[Neurology].

Revue medicale suisse

[Article in French]
Arseny A Sokolov, Andrea O Rossetti, Patrik Michel, David Benninger, Bernard Nater, Christian Wider, Lorenz Hirt, Thierry Kuntzer, Jean-François Démonet, Renaud A Du Pasquier, François Vingerhoets

PMID: 26946707

Abstract

In 2015, cerebral stimulation becomes increasingly established in the treatment of pharmacoresistant epilepsy. Efficacy of endovascular treatment has been demonstrated for acute ischemic stroke. Deep brain stimulation at low frequency improves dysphagia and freezing of gait in Parkinson patients. Bimagrumab seems to increase muscular volume and force in patients with inclusion body myositis. In cluster-type headache, a transcutaneous vagal nerve stimulator is efficient in stopping acute attacks and also reducing their frequency. Initial steps have been undertaken towards modulating memory by stimulation of the proximal fornix. Teriflunomide is the first oral immunomodulatory drug for which efficacy has been shown in preventing conversion from clinical isolated syndrome to multiple sclerosis.

MeSH terms

Publication Types